These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1953 related items for PubMed ID: 11956428

  • 21. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [Abstract] [Full Text] [Related]

  • 22. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
    Escudero Barrilero A, Fernández Fernández E, Jiménez Cidre M, Maganto Pavón E, Mayayo Dehesa T, Rodríguez Rodríguez R, Galvis San Juan F, Burgos Revilla FJ.
    Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191
    [Abstract] [Full Text] [Related]

  • 23. The treated natural history of high risk superficial bladder cancer: 15-year outcome.
    Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR.
    J Urol; 1997 Jul; 158(1):62-7. PubMed ID: 9186324
    [Abstract] [Full Text] [Related]

  • 24. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 25. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].
    Kriegmair M, Waidelich R, Baumgartner R, Lumper W, Ehsan A, Hofstetter A.
    Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172
    [Abstract] [Full Text] [Related]

  • 26. Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder.
    Daneshmand S, Stein JP, Lesser T, Quek ML, Nichols PW, Miranda G, Cai J, Groshen S, Skinner EC, Skinner DG.
    J Urol; 2004 Jul; 172(1):81-4. PubMed ID: 15201742
    [Abstract] [Full Text] [Related]

  • 27. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
    Golijanin D, Yossepowitch O, Beck SD, Sogani P, Dalbagni G.
    J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
    [Abstract] [Full Text] [Related]

  • 28. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD, Sosa RE, Vaughan ED, Scherr DS.
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [Abstract] [Full Text] [Related]

  • 29. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS.
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [Abstract] [Full Text] [Related]

  • 30. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
    Holzbeierlein JM, Lopez-Corona E, Bochner BH, Herr HW, Donat SM, Russo P, Dalbagni G, Sogani PC.
    J Urol; 2004 Sep; 172(3):878-81. PubMed ID: 15310988
    [Abstract] [Full Text] [Related]

  • 31. Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.
    Gupta NP, Kolla SB, Seth A, Hemal AK, Dogra PN, Kumar R.
    J Urol; 2007 Oct; 178(4 Pt 1):1206-11; discussion 1211. PubMed ID: 17698145
    [Abstract] [Full Text] [Related]

  • 32. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I, Miyake H, Harada K, Hara I, Inoue TA, Fujisawa M.
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Seminal sparing cystectomy and ileocapsuloplasty: long-term followup results.
    Muto G, Bardari F, D'Urso L, Giona C.
    J Urol; 2004 Jul; 172(1):76-80. PubMed ID: 15201741
    [Abstract] [Full Text] [Related]

  • 36. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T, Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [Abstract] [Full Text] [Related]

  • 37. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M, Tao R, Zhang C, Shen Z.
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [Abstract] [Full Text] [Related]

  • 38. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?
    Brauers A, Buettner R, Jakse G.
    J Urol; 2001 Mar; 165(3):808-10. PubMed ID: 11176474
    [Abstract] [Full Text] [Related]

  • 39. Upper urinary tract recurrence following radical cystectomy for bladder cancer.
    Furukawa J, Miyake H, Hara I, Takenaka A, Fujisawa M.
    Int J Urol; 2007 Jun; 14(6):496-9. PubMed ID: 17593092
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 98.